424 Capital exits health engagement firm Reverba in strategic sale
Thursday, November 19, 2026 · first reported by PEI Private Equity
424 Capital exited health engagement firm Reverba in a strategic sale.
- Firm
- 424 Capital
- Also named
- Reverba
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
- Pantheon strikes €548m infrastructure secondaries deal with Mirova to back European renewablesAltAssets +2
- Kraken Parent Payward agreed to acquire Tribe Capital, a $2.7 billion venture firm, to build Private-Market ProductsHedgeCo +2
- UBS funds buy Uetlihof for 850 million Swiss francsfinews.com
- Permira and Freeman Spogli to buy Brunt Workwear at over $800m valuationPrivate Equity Wire
- KKR completes $5.7bn take-private of medical device manufacturer IntegerPEI Private Equity
- Blackstone-backed Aster DM eyes $150m India hospital dealPrivate Equity Wire
Got news? Send it to us →